Aoke Medical: Qilentianyou plans to reduce 1% of its holdings.

Omeprazole Medical Announcement: Shareholder Beijing Qilun Tianyou Entrepreneurship Investment Co., Ltd. holds 8.468 million shares of the company, accounting for 6.18%. They plan to reduce their holdings by no more than 1% by centralized bidding and block trading, totaling no more than 1.355 million shares, with the reduction period from October 23, 2025 to January 23, 2026. The reason for the reduction is for their own capital arrangement.